Feb 08, 2017 21:14 pm UTC| Business
MCLEAN, Va., Feb. 08, 2017 -- Gladstone Capital Corporation (NASDAQ:GLAD) (the “Company”) today announced earnings for its first fiscal quarter ended December 31, 2016. Please read the Company’s Quarterly Report on Form...
Whole Foods Market Reports First Quarter Results
Feb 08, 2017 21:13 pm UTC| Business
AUSTIN, Texas, Feb. 08, 2017 -- Whole Foods Market, Inc. (NASDAQ:WFM) today reported results for the 16-week first quarter ended January15, 2017. For the quarter, total sales increased 1.9% to a record $4.9 billion....
AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2016
Feb 08, 2017 21:10 pm UTC| Business
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Feb. 08, 2017 -- Applied Genetic Technologies Corporation (NASDAQ:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene...
Fidelity D & D Bancorp, Inc. Increases First Quarter 2017 Dividend
Feb 08, 2017 21:10 pm UTC| Business
DUNMORE, Pa., Feb. 08, 2017 -- The Board of Directors of Fidelity D D Bancorp, Inc. (OTC US:FDBC), parent company of The Fidelity Deposit and Discount Bank, announce their declaration of the Company’s first quarter...
Imperva to Sell Skyfence Product Line to Forcepoint
Feb 08, 2017 21:10 pm UTC| Business
REDWOOD SHORES, Calif., Feb. 08, 2017 -- Imperva, Inc. (NASDAQ:IMPV) today announced it has agreed to sell its Skyfence technology and service to Forcepoint. The transaction is subject to customary closing conditions...
Imperva Acquires Data Security Assets from Camouflage Software
Feb 08, 2017 21:10 pm UTC| Business
REDWOOD SHORES, Calif., Feb. 08, 2017 -- Imperva, Inc. (NASDAQ:IMPV), committed to protecting business-critical data and applications in the cloud and on-premises, today announced the company has acquired the assets of...
Five Prime Therapeutics to Present at the LEERINK Partners 6th Annual Global Healthcare Conference
Feb 08, 2017 21:10 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 08, 2017 -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics,...